Curcumin Modulates Viability and Apoptosis-Associated Transcripts in HepG2 Cells
Cureus · 10.11.2026
DOI: 10.7759/cureus.119424 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cureus, erschienen am 10.11.2026. Verfasst von Fatima A Al-Derwish und 6 weiteren Autor:innen. Die Arbeit nennt 28 Literaturangaben.
Abstract (Originalsprache)
IntroductionCurcumin, the principal curcuminoid of turmeric (Curcuma longa), has shown growth-inhibitory activity in hepatocellular carcinoma (HCC) models.This study examined metabolic viability, cell morphology, deathmode distribution, and apoptosis-associated transcripts in HepG2 cells exposed to curcumin within a single time-resolved protocol. MethodsHepG2 cells were exposed to curcumin at 17.0-542.9µM for 24, 48, or 72 hours.Metabolic viability was measured by the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay, and the 50% inhibitory concentration (IC 50 ) at each exposure time was estimated by nonlinear regression.Morphology was examined by hematoxylin and eosin staining, and death-mode distribution by acridine orange/ethidium bromide (AO/EB) staining at the time-matched IC 50 .After 48 hours at the 48-hour IC 50 , the relative p53, BAX, and BCL-2 mRNA expression was measured by quantitative real-time polymerase chain reaction (qPCR).Each endpoint was measured in a single experimental series, with three technical replicate wells per MTT condition and technical duplicate qPCR reactions. ResultsThe MTT-derived IC 50 values were 490.3 µM at 24 hours, 34.9 µM at 48 hours, and 49.0 µM at 72 hours, and the concentration effect on viability was significant at each exposure time (one-way analysis of variance, P < 0.001).Treated cells showed reduced confluence, shrinkage, rounding, detachment, and cellular debris.On AO/EB staining, live cells accounted for 97% of untreated cells and for 75%, 62%, and 57% of cells after 24, 48, and 72 hours at the time-matched IC 50 , with apoptotic fractions (24-33%) exceeding necrotic fractions (1-10%).After 48 hours, relative to untreated cells and normalized to glyceraldehyde-3-phosphate dehydrogenase, p53 and BAX mRNA expression was 1.87-and 1.50-fold, and BCL-2 mRNA expression was 0.76-fold; the BAX/BCL-2 transcript ratio, which does not depend on the reference gene, was 1.9-fold higher. ConclusionsIn HepG2 cells, curcumin reduced MTT-based metabolic viability, and this reduction was accompanied by morphological changes, an AO/EB distribution shifted toward apoptotic cells, and a higher BAX/BCL-2 transcript ratio.These single-series in vitro observations describe a growth-inhibitory response with apoptosis-associated features and provide a basis for replicated, protein-level studies in additional hepatic cell models.
Zitieren
APA
Al-Derwish, F. A., ElGenaidi, A. R., Elamin, A. A., Abdon, F., Abukhattala, E. R., Mustafa, A. B., & Khalil, A. K. H. (2026). Curcumin Modulates Viability and Apoptosis-Associated Transcripts in HepG2 Cells. Cureus. https://doi.org/10.7759/cureus.119424
Vancouver
Al-Derwish FA, ElGenaidi AR, Elamin AA, Abdon F, Abukhattala ER, Mustafa AB, et al. Curcumin Modulates Viability and Apoptosis-Associated Transcripts in HepG2 Cells. Cureus. 2026. doi:10.7759/cureus.119424
BibTeX
@article{AlDerwish2026,
author = {Al-Derwish, Fatima A and ElGenaidi, Abdalla R and Elamin, Abdalla A and Abdon, Faris and Abukhattala, Emhemed R and Mustafa, Ayman B and Khalil, Adil Khalil Hussien},
title = {Curcumin Modulates Viability and Apoptosis-Associated Transcripts in HepG2 Cells},
journal = {Cureus},
year = {2026},
doi = {10.7759/cureus.119424}
}
EUVIMED